| Name | Company | Title | Industry | Location | Country | |
|---|---|---|---|---|---|---|
| Josef Schoell | jsc*****@caratherapeutics.com | Cara Therapeutics | CFO | Biotechnology Research | Shelton, CT, US | |
| Rob Spencer | rsp*****@caratherapeutics.com | Cara Therapeutics | Vice President, Research And Development | Biotechnology Research | Stamford, CT, US | |
| Rick Makara | rma****@caratherapeutics.com | Cara Therapeutics | Vice President, Head of Accounting and Controller | Biotechnology Research | Stamford, CT, US | |
| Joana Goncalves | jgo*******@caratherapeutics.com | Cara Therapeutics | Chief Medical Officer | Biotechnology Research | New York, NY, US | |
| Iris Francesconi | ifr*********@caratherapeutics.com | Cara Therapeutics | Chief Strategy Officer and Head of Investor Relations | Biotechnology Research | New York, NY, US | |
| Frederique Menzaghi | fme******@caratherapeutics.com | Cara Therapeutics | Biotechnology Research | Shelton, CT, US | ||
| Kristine Nograles | kno******@caratherapeutics.com | Cara Therapeutics | Biotechnology Research | Warren, NJ, US | ||
| Mel Hayes | mha***@fulcrumtx.com | fulcrumtx.com | Chief Operating Officer | Boston, MA, US | ||
| Kim Hazen | kha***@fulcrumtx.com | fulcrumtx.com | Chief People Officer | Cambridge, MA, US | ||
| Helge Reisch | hre****@fulcrumtx.com | fulcrumtx.com | Vice President Drug Substance Process Development | Cambridge, MA, US |